Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.
about
A systematic review and meta-analysis of anti-adhesion molecule therapy in patients with active Crohn's disease.Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.Alicaforsen therapy in inflammatory bowel disease.Novel drug delivery strategies for the treatment of inflammatory bowel disease.Sorting nexin 10 acting as a novel regulator of macrophage polarization mediates inflammatory response in experimental mouse colitis.Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.Safety of biologic therapy.Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation.Inflammatory bowel disease: beyond the boundaries of the bowel.Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.Hepatic Overlap Syndrome Improved With Infliximab.Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis.Enemas with N-acetylcysteine can reduce the level of oxidative damage in cells of the colonic mucosa diverted from the faecal stream.Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats.Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells.Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells.
P2860
Q33514539-0B478BD5-66B7-48EA-B877-700DF617D59EQ36007709-72A6DE26-80C3-437A-8D3E-52CF70022748Q36273416-93585E1D-F9B0-417B-A32C-53CFE3FECEBDQ36316765-29B5B66A-34AF-4973-A387-444BE52C0F03Q36560019-66D0010E-252B-46F9-A721-4EC1661A50E9Q36631430-BB5D67EC-17BD-4818-9FC7-52CE47A8B833Q36737339-396FA25C-56A5-40FB-A190-20147D2A9C2EQ37801683-CB9CBBE1-E8A8-4289-9410-8D87D6AC7543Q37886164-94070543-673C-4C4F-A11B-1BF21A857D67Q38997094-9C26C0E1-8A51-4235-A649-BDA43F7120C6Q42318655-9ECF1269-98BD-4C2F-9CB0-257BE81C93B7Q44991332-2484C957-E83C-4E15-A743-A3154C9C904CQ45135707-E104249D-EA81-4851-8E11-5A10E5B64270Q46403782-3F2C9337-ED1C-4D79-B8D7-8890CA27D8E8Q46664235-1D2ADB6C-DE92-4321-8A33-AC7DD052C2B4Q54624599-90E1ABBB-767A-4023-B6C7-3C19460EF816
P2860
Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Review article: the expanding ...... adhesion molecule inhibition.
@ast
Review article: the expanding ...... adhesion molecule inhibition.
@en
type
label
Review article: the expanding ...... adhesion molecule inhibition.
@ast
Review article: the expanding ...... adhesion molecule inhibition.
@en
prefLabel
Review article: the expanding ...... adhesion molecule inhibition.
@ast
Review article: the expanding ...... adhesion molecule inhibition.
@en
P2093
P2860
P1476
Review article: the expanding ...... adhesion molecule inhibition.
@en
P2093
Rutgeerts P
Schreiber S
Van Deventer S
P2860
P304
P356
10.1046/J.1365-2036.2003.01603.X
P407
P577
2003-06-01T00:00:00Z